Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding studyRANSON, M; RECK, M; ANTHONEY, A et al.Annals of oncology. 2010, Vol 21, Num 11, pp 2233-2239, issn 0923-7534, 7 p.Article

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancerCIULEANU, T; TSAI, C.-M; MIDDLETON, G et al.Lung cancer. 2013, Vol 82, Num 2, pp 276-281, issn 0169-5002, 6 p.Article